Hikal Q2 Results
- BSE: 524735
- NSE: HIKAL
- ISIN: INE475B01022
- Sector: Biotechnology & Drugs
BSE
189.30
2.50 (1.34%)
2.50 (1.34%)Volume14.12 K
Updated: Tue 16 Jun, 2026 | 15:27:56
NSE
189.702.45 (1.31%)
2.45 (1.31%)Volume2.64 L
Updated: Tue 16 Jun, 2026 | 15:40:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Hikal Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 352.50 | 394.70 | -10.69% | 409.70 | -13.96% |
| Depreciation/ Amortization | 41.20 | 39.40 | 4.57% | 31.70 | 29.97% |
| Operating Income | -34.00 | -14.30 | 137.76% | 43.20 | 0.00% |
| Net Income | -34.90 | -22.40 | 55.80% | 18.30 | 0.00% |
| Other Operating Expenses Total | 115.40 | 105.60 | 9.28% | 114.00 | 1.23% |
| Net Income Before Taxes | -47.00 | -30.40 | 54.61% | 24.80 | 0.00% |
| Total Revenue | 318.50 | 380.40 | -16.27% | 452.90 | -29.68% |
| Selling/ General/ Admin Expenses Total | 69.60 | 62.90 | 10.65% | 62.10 | 12.08% |
| Diluted Normalized EPS | -2.83 | -1.82 | 55.49% | 1.48 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.